Skip to content

Effect of rhomboidal intercostal block combined with intravenous autoanalgesia on multi-mode analgesia and short-term immune function

Effect of rhomboidal intercostal block combined with intravenous autoanalgesia on multi-mode analgesia and short-term immune function

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025926
Enrollment
Unknown
Registered
2019-09-14
Start date
2019-09-15
Completion date
Unknown
Last updated
2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pain?thoracic injury

Interventions

experimental group:Rhomboidal intercostal block combined with controlled intravenous analgesia
control group:controlled intravenous analgesia

Sponsors

The First Affiliated Hospital of Shihezi University Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years; 2. BMI: 18 to 25 kg/m2; 3. American college of anesthesiologists (ASA) grade I-II; 4. Preoperative, intraoperative or postoperative pathological confirmation of primary lung cancer; 5. The patient himself informed and signed or his family members signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Allergic history of local anesthetics; 2. Local or systemic infection at the injection site; 3. Coagulation dysfunction; 4. Gastrointestinal ulcer bleeding; 5. Platelet dysfunction; 6. Changes in surgical methods during surgery; 7. History of perioperative blood transfusion; 8. Communication problems with patients. 9. History of serious cardiovascular, endocrine or liver or kidney diseases; 10. History of use of psychotropic drugs, opioids or non-steroidal anti-inflammatory drugs (NSAID); 11. Long-term hormone and immunosuppressive therapy. 12. History of cytological treatment; 13. History of heavy drinking.

Design outcomes

Primary

MeasureTime frame
NRS;VAS;BCS;Analgesic pump press times and total;

Secondary

MeasureTime frame
T lymphocyte;Usage of remifentanil;NK cells;SII;

Countries

China

Contacts

Public ContactXiwei Dong

Department of Anesthesiology, the First Affiliated Hospital of Shihezi University Medical College

dede123@163.com+86 15709912327

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026